| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(00)02727-6 |
| P8608 | Fatcat ID | release_7efzviuugvcfroxx6wf6xsjt74 |
| P3181 | OpenCitations bibliographic resource ID | 75810 |
| P698 | PubMed publication ID | 11009139 |
| P50 | author | Maria A Quigley | Q50652983 |
| P2093 | author name string | A Ojwiya | |
| A Smith | |||
| B Mayanja | |||
| D Morgan | |||
| H Eotu | |||
| J Whitworth | |||
| M Okongo | |||
| N Omoding | |||
| S Malamba | |||
| P2860 | cites work | The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration | Q28141103 |
| Relation between falciparum malaria and HIV seropositivity in Ndola, Zambia | Q35702348 | ||
| HIV-1 and parasitic infections in rural Tanzania | Q38883501 | ||
| Rainfall pattern, El Niño and malaria in Uganda | Q38886475 | ||
| Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children | Q38887640 | ||
| An HIV-1 natural history cohort and survival times in rural Uganda | Q38887858 | ||
| Two-year HIV-1-associated mortality in a Ugandan rural population | Q38889508 | ||
| The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection | Q38890950 | ||
| Immunological effects of HIV-1 infection on the humoral response to malaria in an African population | Q38891134 | ||
| Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. | Q38912058 | ||
| Is there an interaction between human immunodeficiency virus and Plasmodium falciparum? | Q38938269 | ||
| Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children | Q39032318 | ||
| Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso | Q39250463 | ||
| Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda | Q39256742 | ||
| Prognostic indicators in adult cerebral malaria: a study in Burundi, an area of high prevalence of HIV infection. | Q39306364 | ||
| Attributable fraction estimates and case definitions for malaria in endemic areas | Q39473645 | ||
| Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi. | Q39489373 | ||
| Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire | Q40758958 | ||
| HIV and cerebral malaria | Q41820249 | ||
| Comparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi | Q41931857 | ||
| Plasmodium falciparum antigen-induced human immunodeficiency virus type 1 replication is mediated through induction of tumor necrosis factor-alpha | Q45757919 | ||
| P433 | issue | 9235 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Uganda | Q1036 |
| malaria | Q12156 | ||
| HIV | Q15787 | ||
| immunosuppression | Q1455316 | ||
| P304 | page(s) | 1051-6 | |
| P577 | publication date | 2000-09-23 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study | |
| P478 | volume | 356 |
| Q41924572 | A Study of Malaria Parasite Density in HIV-1 Positive Under-fives in Benin City, Nigeria |
| Q36309128 | A cross-sectional study of sub-clinical Plasmodium falciparum infection in HIV-1 infected and uninfected populations in Mozambique, South-Eastern Africa |
| Q40660291 | A malaria vaccine in children with HIV. |
| Q40528225 | A prospective study of bloodstream infections as cause of fever in Malawi: clinical predictors and implications for management |
| Q43219081 | Acquired immunity in a holoendemic setting of Plasmodium falciparum and p. Vivax malaria. |
| Q38873795 | Altered consciousness in Ugandan hospital admissions |
| Q27341794 | Altered immune responses in rhesus macaques co-infected with SIV and Plasmodium cynomolgi: an animal model for coincident AIDS and relapsing malaria |
| Q40410476 | An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection. |
| Q30424362 | Antimalaria action of antiretroviral drugs on Plasmodium berghei in mice |
| Q42910139 | Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors |
| Q35722064 | Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya? |
| Q35286119 | Artemether-lumefantrine co-administration with antiretrovirals: population pharmacokinetics and dosing implications |
| Q24235145 | Artemisinin-based combination therapy for uncomplicated P. falciparum malaria in children with HIV |
| Q26471338 | Artemisinin-based combination therapy for uncomplicatedP. falciparummalaria in children with HIV |
| Q37185859 | Asexual and sexual stages of Plasmodium falciparum in Nigerian pregnant women attending antenatal booking clinic |
| Q36627614 | Association of HIV-Induced Immunosuppression and Clinical Malaria in Nigerian Adults |
| Q38872084 | Breastfeeding and the Risk of Malaria in Children Born to HIV-Infected and Uninfected Mothers in Rural Uganda |
| Q36376534 | Burden of malaria among adult patients attending general medical outpatient department and HIV care and treatment clinics in Oromia, Ethiopia: a comparative cross-sectional study |
| Q44471772 | CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial |
| Q35692134 | Cardiac Conduction Safety during Coadministration of Artemether-Lumefantrine and Lopinavir/Ritonavir in HIV-Infected Ugandan Adults |
| Q39130334 | Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya |
| Q24791610 | Chagas' disease and AIDS |
| Q21032537 | Clinical aspects of uncomplicated and severe malaria |
| Q36624183 | Co-infection of malaria with HIV: an immunological perspective |
| Q38875931 | Co-trimoxazole, cART, and non-AIDS infectious diseases |
| Q39433868 | Cofactor infections and HIV epidemics in developing countries: implications for treatment |
| Q36931785 | Community-wide Prevalence of Malaria Parasitemia in HIV-Infected and Uninfected Populations in a High-Transmission Setting in Uganda |
| Q37281278 | Complexity, cofactors, and the failure of AIDS policy in Africa |
| Q35180117 | Concurrent sexual partnerships do not explain the HIV epidemics in Africa: a systematic review of the evidence |
| Q37893776 | Consequences of HIV infection on malaria and therapeutic implications: a systematic review |
| Q36418338 | Correlates of HIV and malaria co-infection in Southern India |
| Q43947376 | Cross-sectional relationship between HIV, lymphatic filariasis and other parasitic infections in adults in coastal northeastern Tanzania |
| Q38456034 | Developing an evidence-based, preventive care package for persons with HIV in Africa |
| Q36249062 | Diagnosis, clinical presentation, and in-hospital mortality of severe malaria in HIV-coinfected children and adults in Mozambique |
| Q37693285 | Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era. |
| Q35602042 | Drug interactions in the treatment and chemoprophylaxis of malaria in HIV infected individuals in sub Saharan Africa |
| Q37539183 | Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria |
| Q34732640 | Effect of HIV infection on the acute antibody response to malaria antigens in children: an observational study |
| Q40780160 | Effect of HIV-1 Serostatus on the Prevalence of Asymptomatic Plasmodium falciparum Parasitemia Among Children Less Than 5 Years of Age in Benin City, Nigeria |
| Q35902649 | Effect of HIV-1 infection on malaria treatment outcome in Ugandan patients |
| Q28302553 | Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study |
| Q34359439 | Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda |
| Q38879589 | Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study |
| Q28084902 | Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa |
| Q35739147 | Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study |
| Q24240661 | Effect of preventive interventions for malaria on HIV-1 disease progression in non-pregnant adults |
| Q24197548 | Effect of preventive interventions for malaria on HIV-1 disease progression in non-pregnant adults |
| Q37116879 | Effectiveness of two antifolate prophylactic strategies against malaria in HIV-positive pregnant women in Bangui, Central African Republic: study protocol for a randomized controlled trial (MACOMBA) |
| Q92280942 | Effects of malaria/helminthic coinfections on cervical cancer progression among sub Saharan African women on highly active antiretroviral therapy: A scoping review |
| Q43795095 | Enhanced T cell activation in Plasmodium falciparum malaria-infected human immunodeficiency virus-1 patients from Mozambique |
| Q34177472 | Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination |
| Q39390393 | Estimates of eligibility for antiretroviral treatment (ART) and projected ART impact on AIDS mortality among South African educators |
| Q46901982 | Evaluation of CD4+ T cells in HIV patients presenting with malaria at the University of Ilorin Teaching Hospital Nigeria |
| Q35531240 | Evidence for an increased risk of transmission of simian immunodeficiency virus and malaria in a rhesus macaque coinfection model |
| Q37492591 | Existing antimalarial agents and malaria-treatment strategies |
| Q38786988 | Experimental systems for studying Plasmodium/HIV coinfection |
| Q33209853 | Exploring 30 years of malaria case data in KwaZulu-Natal, South Africa: part II. The impact of non-climatic factors |
| Q37041441 | Falciparum malaria and HIV-1 in hospitalized adults in Maputo, Mozambique: does HIV-infection obscure the malaria diagnosis? |
| Q30379957 | Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda. |
| Q33650105 | Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of Amer |
| Q30388860 | HIV Malaria Co-Infection Is Associated with Atypical Memory B Cell Expansion and a Reduced Antibody Response to a Broad Array of Plasmodium falciparum Antigens in Rwandan Adults |
| Q56793045 | HIV and Malaria: An Immunologic Perspective |
| Q37984496 | HIV and malaria interactions: where do we stand? |
| Q43945786 | HIV and parasitic co-infections in tuberculosis patients: a cross-sectional study in Mwanza, Tanzania |
| Q47956155 | HIV infection among paediatric in-patients in Blantyre, Malawi |
| Q36153767 | HIV infection and the incidence of malaria among HIV-exposed children from Tanzania |
| Q28198124 | HIV infection and tropical parasitic diseases - deleterious interactions in both directions? |
| Q60300766 | HIV infection compounds the lymphopenia associated with cerebral malaria in Malawian children |
| Q93018901 | HIV infection drives IgM and IgG3 subclass bias in Plasmodium falciparum-specific and total immunoglobulin concentration in Western Kenya |
| Q33785634 | HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria |
| Q82029721 | HIV neurology in the developing world |
| Q30373475 | HIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites. |
| Q33578923 | HIV protease inhibitors, indinavir or nelfinavir, augment antimalarial action of artemisinin in vitro |
| Q44189539 | HIV-1 infection and malaria parasitaemia |
| Q47878210 | HIV-1 infection and malaria parasitaemia |
| Q56920055 | HIV-1 infection and malaria parasitaemia |
| Q35689395 | HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study |
| Q47968203 | HIV-1, antiretroviral therapy, and malaria |
| Q34714438 | HIV-1/AIDS and the control of other infectious diseases in Africa |
| Q37120966 | HIV-1/parasite co-infection and the emergence of new parasite strains |
| Q38868223 | HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea |
| Q40106098 | HIV-malaria interactions in North-East India: A prospective cohort study |
| Q30392186 | HIV-positive nigerian adults harbor significantly higher serum lumefantrine levels than HIV-negative individuals seven days after treatment for Plasmodium falciparum infection |
| Q34983798 | Hematological predictors of increased severe anemia in Kenyan children coinfected with Plasmodium falciparum and HIV-1. |
| Q36919663 | Human immunodeficiency virus (HIV) and malaria interaction in sub-Saharan Africa: the collision of two Titans |
| Q37364317 | Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in Western Kenya. |
| Q33793608 | Human immunodeficiency virus infection and cerebral malaria in children in Uganda: a case-control study |
| Q36123104 | Humoral immune responses to Plasmodium falciparum among HIV-1-infected Kenyan adults |
| Q39362892 | Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum |
| Q27006923 | Immunological disturbances associated with malarial infection |
| Q36785435 | Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents |
| Q26775212 | Immunoregulation in human malaria: the challenge of understanding asymptomatic infection |
| Q37724300 | Impact of comorbidity on adverse drug reaction profile in a cohort of patients treated with Artemisinin combination therapies for uncomplicated malaria in Nigeria. |
| Q41937928 | Impact of delayed introduction of sulfadoxine-pyrimethamine and arthemeter-lumefantrine on malaria epidemiology in KwaZulu-Natal, South Africa |
| Q56339581 | Impact of efavirenz, ritonavir-boosted lopinavir and nevirapine based antiretroviral regimens on the pharmacokinetics of lumefantrine and safety of artemether-lumefantrine in -negative HIV-infected Malawian adults stabilized on antiretroviral therapy |
| Q36539086 | Impact of human immunodeficiency virus infection in pregnant women on variant-specific immunity to malaria |
| Q47380118 | Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection |
| Q42046734 | Imported Plasmodium falciparum malaria in HIV-infected patients: a report of two cases |
| Q33874151 | Incidence of malaria-related fever and morbidity due to Plasmodium falciparum among HIV1-infected pregnant women: a prospective cohort study in South Benin |
| Q46977081 | Increased prevalence of severe malaria in HIV-infected adults in South Africa |
| Q37203716 | Increased risk for severe malaria in HIV-1-infected adults, Zambia |
| Q36384846 | Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa |
| Q28216712 | Interactions between malaria and HIV infection-an emerging public health problem? |
| Q34404275 | Interactions between malaria and human immunodeficiency virus anno 2014 |
| Q44160757 | Intermittent preventive treatment during pregnancy with sulphadoxine-pyrimethamine may promote Plasmodium falciparum gametocytogenesis |
| Q24236135 | Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women |
| Q24244574 | Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women |
| Q36872926 | International perspectives, progress, and future challenges of paediatric HIV infection |
| Q37097177 | Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study |
| Q35883504 | Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults |
| Q36214299 | Macrophage Colony Stimulating Factor Derived from CD4+ T Cells Contributes to Control of a Blood-Borne Infection |
| Q55878749 | Malaria |
| Q56420006 | Malaria |
| Q37299109 | Malaria and HIV co-infection and their effect on haemoglobin levels from three health-care institutions in Lagos, southwest Nigeria |
| Q37043258 | Malaria and Human Immunodeficiency Virus Infection |
| Q36033898 | Malaria and hiv in adults: when the parasite runs into the virus |
| Q21032444 | Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa |
| Q34289235 | Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens |
| Q39665329 | Malaria hidden in a patient with diffuse large-B-cell lymphoma and sickle-cell trait |
| Q38940216 | Malaria in injection drug abusers in Vietnam |
| Q36611035 | Malaria in the Traveler: How to Manage Before Departure and Evaluate Upon Return |
| Q30419284 | Malaria is an uncommon cause of adult sepsis in south-western Uganda |
| Q43949079 | Malaria parasitaemia in relation to HIV status and vitamin A supplementation among pre-school children |
| Q33749682 | Malaria parasitemia and CD4 T cell count, viral load, and adverse HIV outcomes among HIV-infected pregnant women in Tanzania |
| Q35880187 | Maternal malaria and perinatal HIV transmission, western Kenya |
| Q39473674 | Measures of clinical malaria in field trials of interventions against Plasmodium falciparum |
| Q92131935 | Modelling the relationship between malaria prevalence as a measure of transmission and mortality across age groups |
| Q35829744 | Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults |
| Q33999657 | No evidence of association between HIV-1 and malaria in populations with low HIV-1 prevalence |
| Q57029497 | On the epidemiology of Plasmodium vivax malaria: past and present with special reference to the former USSR |
| Q39198710 | Opportunistic infections associated with HIV infection in Africa. |
| Q33733033 | Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy |
| Q37047567 | Over-diagnosis and co-morbidity of severe malaria in African children: a guide for clinicians. |
| Q89738394 | PREVALENCE AND CLINICAL FORMS OF MALARIA AMONG FEBRILE HIV-INFECTED CHILDREN SEEN AT USMANU DANFODIYO UNIVERSITY TEACHING HOSPITAL, SOKOTO, NIGERIA |
| Q35532952 | Parasite Specific Antibody Increase Induced by an Episode of Acute P. falciparum Uncomplicated Malaria |
| Q31155229 | Parasite interactions in natural populations: insights from longitudinal data |
| Q36328956 | Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis |
| Q35716404 | Performance of two malaria rapid diagnostic tests in febrile adult patients with and without human immunodeficiency virus-1 infection in Blantyre, Malawi |
| Q36144257 | Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults |
| Q54212174 | Pharmacokinetics and safety profile of artesunate-amodiaquine co-administered with antiretroviral therapy in malaria uninfected HIV-positive Malawian adults. |
| Q56355681 | Pharmacokinetics of Piperaquine and Safety Profile of Dihydroartemisinin-Piperaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults |
| Q91265586 | Physiologically-Based Pharmacokinetic Modeling for Optimal Dosage Prediction of Quinine Coadministered With Ritonavir-Boosted Lopinavir |
| Q40286305 | Placental malaria is associated with increased risk of nonmalaria infection during the first 18 months of life in a Beninese population |
| Q89795919 | Plasma parasitemia as assessed by quantitative PCR in relation to clinical disease severity in African adults with falciparum malaria with and without HIV co-infection |
| Q34801934 | Plasmodium falciparum Infection Does Not Affect Human Immunodeficiency Virus Viral Load in Coinfected Rwandan Adults. |
| Q24805078 | Postpartum maternal morbidity requiring hospital admission in Lusaka, Zambia - a descriptive study |
| Q33195599 | Potential effect of climate change on malaria transmission in Africa |
| Q37351962 | Predictors of fetal anemia and cord blood malaria parasitemia among newborns of HIV-positive mothers |
| Q89733528 | Predictors of outcome in childhood Plasmodium falciparum malaria |
| Q35656242 | Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population |
| Q33583769 | Prevalence and correlates of insecticide-treated bednet use among HIV-1-infected adults in Kenya |
| Q36743880 | Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies |
| Q34493927 | Prevalence of clinically captured and confirmed malaria among HIV seropositve clinic attendants in five hospitals in Ghana |
| Q44150527 | Problems in prescribing malaria chemoprophylaxis for travelers |
| Q37084647 | Progression to WHO criteria for antiretroviral therapy in a 7-year cohort of adult HIV-1 seroconverters in Abidjan, Côte d'Ivoire |
| Q42263673 | Provision of bednets and water filters to delay HIV-1 progression: cost-effectiveness analysis of a Kenyan multisite study |
| Q36792779 | Quantification of the burden and consequences of pregnancy-associated malaria in the Democratic Republic of the Congo |
| Q29395484 | Race, Sex, and the Neglected Risks for Women and Girls in Sub-Saharan Africa |
| Q36265007 | Regulation of immune response by Plasmodium-infected red blood cells. |
| Q22242974 | Review of Human Immunodeficiency Virus Type 1–Related Opportunistic Infections in Sub‐Saharan Africa |
| Q38884540 | Risk factors and cumulative incidence of anaemia among human immunodeficiency virus-infected children in Uganda. |
| Q33286814 | Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort |
| Q36936342 | SHIV antigen immunization alters patterns of immune responses to SHIV/malaria coinfection and protects against life-threatening SHIV-related malaria |
| Q35078624 | Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial |
| Q21133667 | Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review |
| Q35053376 | Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults |
| Q36300127 | Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults |
| Q36556133 | Simulation of malaria epidemiology and control in the highlands of Western Kenya |
| Q34005264 | Statistical inference for multi-pathogen systems |
| Q34611339 | Supplementation with multivitamins and vitamin A and incidence of malaria among HIV-infected Tanzanian women |
| Q30040102 | Syringe-Mediated Syndemics |
| Q36052615 | T-cell depletion and immunity to malaria in HIV-infections |
| Q56350030 | The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study |
| Q37206613 | The Effect of Malaria and HIV Co-Infection on Anemia: A Meta-Analysis |
| Q37297061 | The Impact of HIV and Malaria Coinfection: What Is Known and Suggested Venues for Further Study |
| Q46594461 | The Interaction between HIV and malaria in Africa |
| Q35914418 | The association between malnutrition and the incidence of malaria among young HIV-infected and -uninfected Ugandan children: a prospective study |
| Q36450099 | The effect of HIV infection on the risk, frequency, and intensity of Plasmodium falciparum parasitemia in primigravid and multigravid women in Malawi |
| Q36504556 | The effect of HIV on malaria in the context of the current standard of care for HIV-infected populations in Africa |
| Q36319202 | The effect of HIV on morbidity and mortality in children with severe malarial anaemia |
| Q38880540 | The effect of malaria on mortality in a cohort of HIV-infected Ugandan adults |
| Q35884247 | The immunological challenge to developing a vaccine to the blood stages of malaria parasites. |
| Q36840133 | The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance |
| Q39154381 | The interaction between malaria and human immunodeficiency virus infection in severely anaemic Malawian children: a prospective longitudinal study. |
| Q34572160 | Towards a blood-stage vaccine for malaria: are we following all the leads? |
| Q28740539 | True versus false parasite interactions: a robust method to take risk factors into account and its application to feline viruses |
| Q33635019 | Update on the efficacy, effectiveness and safety of artemether-lumefantrine combination therapy for treatment of uncomplicated malaria. |
| Q37114810 | Use of insecticide treated net and malaria preventive education: effect on malaria parasitemia among people living with AIDS in Nigeria, a cross-sectional study |
| Q38877456 | Utilization of a basic care and prevention package by HIV-infected persons in Uganda |
| Q35557138 | Virus infection stages and distinct Th1 or Th17/Th22 T-cell responses in malaria/SHIV coinfection correlate with different outcomes of disease |
| Q35761561 | Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part 1: determinants operating at individual and household level |
| Q46300781 | What Do We Know about Risk Factors for Fetal Growth Restriction in Africa at the Time of Sustainable Development Goals? A Scoping Review |
| Q57873218 | Wild African great apes as natural hosts of malaria parasites: current knowledge and research perspectives |
| Q87345715 | [Traveling with immunosuppression] |
Search more.